Don't Miss

CT’s Pfizer acquires obesity drug start-up. A ‘strategic milestone,’ pharmaceutical giant CEO said

Pfizer noted it has completed its acquisition of all outstanding shares of the company’s common stock for $65.60 per share in cash, representing an enterprise value of approximately $7 billio…

Read Story